Relationship between the type of hormone replacement therapy and incidence of breast cancer in Korea.
J K BaekHye In KimM J KangK E SeonEui Hyeok KimSeok Kyo SeoPublished in: Climacteric : the journal of the International Menopause Society (2022)
For women in their 50s, tibolone use lowers BCR; for all ages, the use of any HRT for >5 years showed lower BCR in Korea. These divergent results from western countries could be associated with the specific characteristics of BC in Korea.